|
June 10, 2016
|
Highlights from ASCO |
|
Biosimilars will have a significant impact on cancer treatment, with the potential to drive cost savings. But will patients and providers be accepting? Read more. |
|
Most patients hear the word "cancer" and believe they may die if they do not seek treatment. But ASCO presenters say that may be a problematic mentality. Read more. |
|
De-escalated maintenance or drug holidays: What's best for patients with metastatic colorectal cancer? Read more. |
Top oncology content |
|
|
|
|
We welcome your feedback!
Please send your comments to:
Aubrey Westgate
Executive Editor
Managed Healthcare Executive
[email protected] |
DISCLAIMER:
This information has been independently developed and provided by the editors of Managed Healthcare Executive. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
